FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 1544802 · Received November 4, 2009

Report

Report Number
2027969-2009-01003
Event Type
Malfunction
Date Received
November 4, 2009
Date of Event
October 15, 2009
Report Date
November 4, 2009
Manufacturer
BIOSITE INCORPORATED
Product Code
GJS
PMA / PMN Number
021923
Removal / Correction Number
NI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DISCREPANT RESULTS (ACCURACY). COMPARISON OF INRATIO TEST WITH LAB RESULTS PROVIDED BY END-USER AT TIME COMPLAINT WAS FILED. THE MEAN OF THE INRATIO METER AND COMPARATIVE SYSTEM INR WERE CALCULATED. REFERENCE VALUE ON TEST 2 FALLS OUTSIDE LIMITS, SO THE CRITERIA IS NOT MET AND THE VALUE IS DISCREPANT BEYOND THE DOCUMENTED VARIABILITY FOR PT/INR TESTING. THIS WOULD BE SUBJECT TO STRIPS ACCURACY TESTING AS PART OF THE COMPLAINT INVESTIGATION. MEAN CALCULATION FROM COMPARISON TEST DATA PROVIDED BY END-USER REVEALED BOTH REFERENCE VALUE ON TEST-2 WAS OUTSIDE OF THE HIGHER CONFIDENCE LIMIT FOR INR TESTING. METER AND STRIPS WERE NOT EXPECTED TO BE RETURNED. RETAIN STRIP TESTS WERE PERFORMED. PRODUCT DEFICIENCY WAS NOT ESTABLISHED. THERE IS NOT SUFFICIENT INFO TO DETERMINE THE ROOT CAUSE OF END-USER'S DISCREPANCY. FURTHER TEST IS NOT REQUIRED AT THIS TIME. AS OF 10/26/2009, 14 DISCREPANT RESULT COMPLAINTS WERE REPORTED FOR LOT #213040 YIELDING A COMPLAINT RATE OF 0.004%. DUE TO THE LOW OCCURRENCE RATE BELOW THE ACTION THRESHOLDS MONITORED BY QA FOR CORRECTIVE ACTION (>0.07%), NO FURTHER ACTION IS REQUIRED AT THIS TIME. ONGOING TRENDING SHALL BE PERFORMED TO DETERMINE IF FURTHER ACTION IS WARRANTED.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH THE LAB. RESULTS AS FOLLOWS: DATE: (B)(6) 2009. INRATIO: 1.4. LAB: 2.6. POC METER: 2.8.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST GJS BIOSITE INCORPORATED 0100139 213040

Patients

Seq Age Sex Outcome Treatment
1 NI